Within the TME, eosinophils activated by TNF-α and IFN-γ release chemokines such as CXCL9 and CXCL10, promoting CD4+ and CD8+ T cell infiltration and enhancing anti-tumor immune responses (65). The gene discussed is IFNG; the disease is neoplasm.